122 related articles for article (PubMed ID: 31319587)
21. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.
Ning N; Zhan T; Zhang Y; Chen Q; Feng F; Yang Z; Liu Z; Xu D; Wang F; Guo Y; Xing J; Guan Y; Cui W
Clin Chim Acta; 2014 Jun; 433():69-75. PubMed ID: 24607330
[TBL] [Abstract][Full Text] [Related]
22. Fiber-Optic Array Scanning Technology (FAST) for Detection and Molecular Characterization of Circulating Tumor Cells.
Ao Z; Liu X
Methods Mol Biol; 2017; 1634():235-246. PubMed ID: 28819856
[TBL] [Abstract][Full Text] [Related]
23. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.
Chebouti I; Kuhlmann JD; Buderath P; Weber S; Wimberger P; Bokeloh Y; Hauch S; Kimmig R; Kasimir-Bauer S
Oncotarget; 2017 Apr; 8(15):24303-24313. PubMed ID: 28388557
[TBL] [Abstract][Full Text] [Related]
24. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
[TBL] [Abstract][Full Text] [Related]
25. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
26. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
[TBL] [Abstract][Full Text] [Related]
27. Expression of WT1 and PAX8 in the epithelial tumours of Malaysian women with ovarian cancer.
Rhodes A; Vallikkannu N; Jayalakshmi P
Br J Biomed Sci; 2017 Apr; 74(2):65-70. PubMed ID: 28367736
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of supradiaphragmatic lymph node metastasis detected by
Lee IO; Lee JY; Kim HJ; Nam EJ; Kim S; Kim SW; Lee CY; Kang WJ; Kim YT
BMC Cancer; 2018 Nov; 18(1):1165. PubMed ID: 30477469
[TBL] [Abstract][Full Text] [Related]
29. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
[TBL] [Abstract][Full Text] [Related]
30. Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.
Cheng X; Zhang L; Chen Y; Qing C
J Ovarian Res; 2017 Nov; 10(1):75. PubMed ID: 29132396
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.
Aktas B; Kasimir-Bauer S; Heubner M; Kimmig R; Wimberger P
Int J Gynecol Cancer; 2011 Jul; 21(5):822-30. PubMed ID: 21613958
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
[TBL] [Abstract][Full Text] [Related]
34. Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples.
Miller B; Lustberg M; Summers TA; Chalmers JJ
Methods Mol Biol; 2017; 1634():219-234. PubMed ID: 28819855
[TBL] [Abstract][Full Text] [Related]
35. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
[TBL] [Abstract][Full Text] [Related]
36. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
[TBL] [Abstract][Full Text] [Related]
37. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
Chen W; Li Y; Yuan D; Peng Y; Qin J
Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
[TBL] [Abstract][Full Text] [Related]
38. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Fizazi K; Morat L; Chauveinc L; Prapotnich D; De Crevoisier R; Escudier B; Cathelineau X; Rozet F; Vallancien G; Sabatier L; Soria JC
Ann Oncol; 2007 Mar; 18(3):518-21. PubMed ID: 17322541
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.
Cui L; Kwong J; Wang CC
J Ovarian Res; 2015 Jun; 8():38. PubMed ID: 26077676
[TBL] [Abstract][Full Text] [Related]
40. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
